logo logo
  • SV
  • |
  • EN
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & policies
  • Careers
  • News & events
    • Inify Laboratories news
    • Events
    • Newsletter
    • Publications & Presentations
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify Laboratories
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Support
    • Investor relations & media
logo logo
  • Start
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • About us
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & Policies
  • Newsroom
    • News
    • Events
    • Newsletter
    • Publications & Presentations
  • Careers
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Visit us
    • Support
    • Investor relations & media
  • SV
  • |
  • EN

Inify Laboratories – Annual Report 2025

Annual reports, Financial reports, Investor News 2026-04-15
Stockholm – April 15, 2026 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, presents its Annual Report for the fiscal year ended December 31, 2025. […]
Read More

Inify Laboratories: Solid topline growth, strong UK development, and positive response to gastrointestinal diagnostics

Financial reports, Investor News 2026-02-25
STOCKHOLM – February 25, 2026 – Inify Laboratories, a unique laboratory service that provides diagnostics within pathology, reports continued sales growth in the fourth quarter of 2025. Significant progress has […]
Read More

Correction – Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026

Financial reports, Investor News 2025-10-29
In connection with the publication of the company's Q3 2025 Financial Report, it was discovered that the amount for personnel costs in the parent company's income statement was incorrect. The […]
Read More

Inify Laboratories: Solid growth in Sweden and first patient diagnostics delivered in the UK

Financial reports, Investor News 2025-08-27
STOCKHOLM – August 27, 2025 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, continues to deliver solid sales growth of 54% in the second quarter, […]
Read More

Inify Laboratories: Continued strong growth – construction and establishment in the UK

Financial reports, Investor News 2025-04-30
STOCKHOLM – April 30, 2025 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, continued to deliver sales growth and positive margins in Sweden, alongside steady […]
Read More

Inify Laboratories – Annual Report 2024

Annual reports, Financial reports, Investor News 2025-04-16
Stockholm – April 16, 2025 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, presents its Annual Report for the fiscal year ended December 31, 2024. […]
Read More

Inify Laboratories: 60% quarterly sales growth and highly positive response to UK expansion

Financial reports, Investor News 2025-02-26
STOCKHOLM – February 26, 2025 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, saw sales grow by 60% compared to the previous quarter, and 472% […]
Read More

Inify Laboratories: Establishment in the United Kingdom and expansion into gastrointestinal diagnostics

Financial reports, Investor News 2024-10-23
STOCKHOLM – October 23, 2024 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, has after extensive market mapping decided to establish operations in the United […]
Read More

INIFY Laboratories: 62% revenue growth and strong international interest

Financial reports, Investor News 2024-08-21
STOCKHOLM – August 21, 2024 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, continues to deliver strong growth, with sales of SEK 3.6 million in […]
Read More

Inify Laboratories – More diagnoses delivered in the first quarter than in the whole of 2023

Financial reports, Investor News 2024-04-24
STOCKHOLM – April 24, 2024 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, saw a 184% increase in sales in Q1 2024, compared to the […]
Read More
  • 1
  • 2
  • 3
  • Our services

    Inify laboratory services

    For urology

    For gastroenterology

    For pathology

    For our customers

    Request a presentation

    Customer cases

    Information & policies

  • Inify Laboratories

    News

    Events

    Newsletter

    Publications & presentations

    Career

  • For Investors

    Invest in Inify Laboratories

    Investor news

    Financial reports (ENG)

    Financial reports (SWE)

    Financial calender

    Sustainability

    The share

    Executive team

    Subscription

     

     

  • Contact us

    +46 (0)8 26 73 30

    Support

    Find Inify Laboratories

  • Social media

    LinkedIn

    YouTube

    X

© Inify® Laboratories